GlassScriptPhysician profile
Daniel Trevor Young
NPI 1114301710
$6,740.41
in general payments reported to CMS, 2019-2025
33 companies · $934 in 2025
The $934 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,046 · 2020: $987 · 2022: $679 · 2023: $802 · 2024: $1,293 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,874 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,873.71 |
| Education | $154.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $870.59 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Astellas Pharma US INC | $790.13 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $659.85 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $479.22 | 2019-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $413.09 | 2019-2024 | Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $409.90 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $408.51 | 2019-2020 | |
| Pfizer INC. | $370.46 | 2019-2025 | |
| Lilly USA, LLC | $354.76 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| E.R. Squibb & Sons, L.L.C. | $313.59 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $287.42 | 2019-2025 | Breztri, Farxiga |
| Allergan, INC. | $243.29 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $241.69 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $236.48 | 2019-2025 | |
| Antares Pharma, INC. | $102.51 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $72.28 | 2019-2022 | |
| Becton, Dickinson and Company | $67.69 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.86 | 2020-2025 | Trintellix |
| Amarin Pharma, INC. | $57.62 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $38.35 | 2019-2020 | |
| Exact Sciences Corporation | $36.41 | 2025 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $29.38 | 2019-2020 | |
| Dexcom, INC. | $27.05 | 2020-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $22.77 | 2025 | Rexulti |
| Acorda Therapeutics, INC | $18.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.53 | 2019 | |
| Sanofi Pasteur INC. | $18.47 | 2019 | |
| Sumitomo Pharma America, INC. | $16.52 | 2023 | Gemtesa |
| Medtronic, INC. | $16.23 | 2025 | Minimed 780g |
| Mannkind Corporation | $15.58 | 2020 | |
| Mdd US Operations, LLC | $15.45 | 2020 | |
| Lifescan, INC. | $15.11 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.